The In Vitro Diagnostics sector covers the field of healthcare products destined for use in vitro on human samples and specimens in order to inform on a physiological state, modify a therapy, etc.
Constituted in 1979, today it is made up of 32 companies and employs approximately 2,000 people. The market in 2004 had a value of some 740 million euros showing a 6% increase on the previous year.
